BRITNEY ROBINSON: Open Payments
NPI 1235851338 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 14 payments from 8 companies in 2025. Trend: 2023 $385 · 2024 $363 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 3 | $168 |
| Novo Nordisk Inc | 4 | $75 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Edwards Lifesciences Corporation | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: SYMPLICITY G3, Ozempic, ONYX FRONTIER, VERQUVO, JARDIANCE, Kerendia, Rybelsus, VYNDAQEL.
Industry payments across AL — which companies pay providers there.
